BusinessApricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by RecordatiBy Nasdaq OMXSep 21, 2016, 11:00 AM UTC
BusinessZafgen Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061By Nasdaq OMXSep 20, 2016, 11:02 AM UTC
BusinessApricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for Vitaros® in Finland and Denmark to Ferring PharmaceuticalsBy Nasdaq OMXSep 20, 2016, 11:01 AM UTC
BusinessFibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXSep 19, 2016, 12:00 PM UTC
BusinessUpdate: ChromaDex will demonstrate how it’s raising the bar on ingredient technology, applications innovation and raw materials testing at SupplySide West 2016By Nasdaq OMXSep 15, 2016, 8:57 PM UTC
BusinessChromaDex will demonstrate how it’s raising the bar on ingredient technology, applications innovation and raw materials testing at SupplySide West 2016By Nasdaq OMXSep 15, 2016, 10:30 AM UTC
BusinessZynerba Pharmaceuticals Reports Inducement Grant to New Chief Financial OfficerBy Nasdaq OMXSep 13, 2016, 8:05 PM UTC
